Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1579910/000157991020000007/resn33120-10q.htm
March 2022
February 2022
February 2022
January 2022
November 2021
October 2021
October 2021
August 2021
July 2021
June 2021
• | Revenues up sequentially over fourth quarter 2019. |
• | Reduced annualized expense run-rate by approximately $5 million. |
• | Signed multiple license agreements with a Tier 1 Chinese foundry for products targeted at the high volume, high value, Tier 1 China mobile market. |
• | Demonstrated XBAR is capable of 1.1 GHz of protected bandwidth at 6.5 GHz, targeting Wi-Fi 6 and Wi-Fi 6E which delivers the full promise of broadband video to phones. |
• | Strengthened the company’s IP portfolio with the issuance of the first XBAR/5G related patents. |
• | Announced an Advisory Board of six industry leaders to aid the company in strategy and tactics for its target markets. |
• | Billings of $280,000. |
• | Revenues of 544,000. |
• | Deferred revenues of $1.5 million. |
• | Research and development expenses of $5.5 million. |
• | Sales, marketing and administration expenses of $3.1 million. |
• | Net loss of $8.0 million, or $(0.18) per share. |
• | Non-GAAP, adjusted EBITDA of $(6.4) million, or $(0.15) per share. |
• | Cash and cash equivalents of $29.6 million as of March 31, 2020. |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1579910/000157991020000007/resn33120-10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Resonant Inc.
Resonant Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Rating
Learn More![]()
However, research and development expenses may continue to increase over the remainder of the year if we determine we need to add replacement headcount.
Our costs include employee salaries and benefits, compensation paid to consultants, capital costs for research and other equipment, costs associated with development activities including travel and administration, legal expenses, sales and marketing costs, general and administration expenses, and other costs associated with a late-stage development, publicly-traded technology company.
These expenses relate to direct engineering and other costs associated with the development and commercialization of our technology, including the development of filter designs for our customers and consist primarily of the compensation costs of employees, including stock-based compensation, and to a lesser extent, development related costs for consultants, equipment, software and supplies.
We anticipate that our research and development expenses will decrease in the next quarter due to reduced headcount as a result of our workforce restructuring that occurred in March 2020.
The increase was primarily related to higher compensation expenses of $700,000 associated with increased headcount and higher development costs of $250,000 related to our ISN software development, XBAR technology development and expanded activity on our filter designs under development.
In the absence of a...Read more
As such, our actual results...Read more
In all licensing arrangements with...Read more
Revenues consist primarily of the...Read more
Our goal is to establish...Read more
The pandemic may also impact...Read more
While we have not yet...Read more
We continue to add employees,...Read more
Research and development expenses increased...Read more
In the first quarter of...Read more
The increase primarily related to...Read more
These expenses relate to our...Read more
Depending on our business outlook...Read more
The words "believe," "may," "will,"...Read more
Overall, the layoffs and executive...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Resonant Inc provided additional information to their SEC Filing as exhibits
Ticker: RESN
CIK: 1579910
Form Type: 10-Q Quarterly Report
Accession Number: 0001579910-20-000007
Submitted to the SEC: Wed May 06 2020 5:33:04 PM EST
Accepted by the SEC: Thu May 07 2020
Period: Tuesday, March 31, 2020
Industry: Semiconductors And Related Devices